GENE ONLINE|News &
Opinion
Blog

ADC
In-Depth ADC
What Are ADCs? Understanding Their Structure and Cancer-Killing Mechanism
2025-05-13
Asia Pacific HoneyBear Biosciences
Singapore’s A*STAR Invests in HoneyBear, Accelerating ARC Cancer Drug Development
2025-03-28
JPM 2025 Layoff
2025 Starts with a Jolt: Layoffs Hit the Life Sciences Industry Ahead of JPM
2025-01-16
Biotech Giants Behind Partnerships in Precision Therapies, Gene Editing, and ADCs
2025-01-03
Biotech T-cellOncology
Ipsen Bets $600M on Biomunex’s First-in-Class T-Cell Engager BMX-502
2024-12-03
Biotech ADC TherapeuticsIndustry Insights
Antibody-Drug Conjugates: Connecting Drugs to Cancer Cells and Unlocking Billions in Market Opportunities
2024-11-06
Deals Oncology Market
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Trending BIOSECURE ActCDMO
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
IPO Hong KongDuality Bio
DualityBio, Partner of BioNTech and BeiGene, Files for Hong Kong IPO, Highlighting Several Potential First-in-Class ADCs
2024-08-29
Special ADC
ROR1 in Focus as a target for ADC-based treatments: Recent Developments and Industry Challenges – Part III
2024-08-07
Ranking & Reports AbbVieQ2 Report
AbbVie’s Q2 2024 Financial Highlights: Growth in Immunology, Oncology, and Neuroscience
2024-08-06
Special ADC
NMT Inhibitors and Next-Gen Nectin-4 ADCs a Field Ripe for Research – Part II
2024-08-01
BIO Asia-Taiwan 2024 BIO Asia-Taiwan Day 1Cell and Gene Therapy
BIO Asia-Taiwan 2024 Conference has Officially Started, With International Leaders in the Industry Gathering Despite the Storm
2024-07-25
Special ADC
Topo-1 and FRα: Key Focus Areas and Major Collaborations in ADC Research – Part I
2024-07-23
Trending ADCFirst-in-class
Foreseen Biotech Strikes $1.03B Deal with Ipsen for First-in-Class ADC
2024-07-12
1 2
LATEST
Regeneron Steps In to Rescue 23andMe From Bankruptcy With $256M Acquisition
2025-05-20
Virtual trial shows combo rescue inhaler nearly halves severe asthma attacks
2025-05-20
Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition
2025-05-19
The Fight Against Hard-to-Treat Cancers : Bold Bets on a Multifaceted Approach
2025-05-19
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-19
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
READ MORE
EVENT
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top